Rival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar ... binding offer by early October. Suven said Advent would make an additional open offer for up to 26 per cent ...

However, Cipla has filed representation for only one brand - Advent 1.2 mg powder vial claiming revised PTR as Rs 111.52 per vial. Besides, the company filed details of Advent 1.2 gm injection vial ...

Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying its Goa facility as “Voluntary Action Indicated” (VAI ...